Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON) announced participation in two upcoming investor conferences. Management will host fireside chats at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 19 at 4:30 p.m. ET and the Jefferies Global Healthcare Conference on June 3 at 3:10 p.m. ET.

Live webcasts and archived replays will be available on the company’s investor relations website.

News Market Reaction – IRON

+1.42%

2 alerts

+1.42% Session close to close

$2.78B Market Cap

0.3x Rel. Volume

In the May 11 session, IRON gained 1.42%, reflecting a mild positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WATERTOWN, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at two upcoming investor conferences:

• H.C. Wainwright 3^rd Annual BioConnect Investor Conference on Tuesday, May 19^th at 4:30 p.m. ET.
  
• Jefferies Global Healthcare Conference on Wednesday, June 3^rd at 3:10 p.m. ET.
  
  

Live webcasts of the fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after each event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com

FAQ

When will Disc Medicine (NASDAQ:IRON) present at the H.C. Wainwright BioConnect Investor Conference?

Disc Medicine will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 19 at 4:30 p.m. ET. According to the company, investors can access this session via live webcast on its investor relations website.

When is Disc Medicine (NASDAQ:IRON) presenting at the Jefferies Global Healthcare Conference 2026?

Disc Medicine is scheduled for a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3 at 3:10 p.m. ET. According to the company, the session will be streamed live and later available as an archived replay online.

How can investors watch Disc Medicine’s upcoming investor conference webcasts (NASDAQ:IRON)?

Investors can watch Disc Medicine’s fireside chats via live webcasts hosted in the investor relations section of its website. According to the company, an archived replay of each event will also be accessible online after the live sessions conclude.

Will replays of Disc Medicine’s May 19 and June 3, 2026 fireside chats be available?

Yes, Disc Medicine plans to provide archived replays of both fireside chats following the live events. According to the company, these recordings will be available through the investor relations section of its website for investors who cannot attend live.